menu

Quintiles Library

Show Filters
White Paper
A risk-based approach to clinical monitoring has been supported by the Food and Drug Administration (FDA), European Medicines Agency (EMA) and others as a new way to facilitate more efficient trial delivery without compromising data quality or patient safety. Quintiles has created Data-driven Trial Execution, a delivery model based on risk-based monitoring principles and...
Explore More
Fact Sheet
Risk-based monitoring (RBM) has become a cornerstone of innovative trial execution. Supported by the FDA and EMA, this approach can deliver greater efficiency while upholding data quality and patient safety. Our solution, Data-driven Trial Execution, leverages enhanced data review processes and timely insights from our breakthrough technology, Quintiles Infosario®...
Read more
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 10, 2015 – Quintiles, the world’s largest biopharmaceutical services company, is working with the National Football League (NFL) to track player injuries and understand trends in injury occurrence. Quintiles and the NFL have been working together since 2011, when the Quintiles epidemiology group was tasked with designing a new...
Read More
Brochure
真实世界研究与临床后期研究正确问题的正确对策
Read More
Brochure
Real-world late phase research is becoming critical to product success Determining the right approach to achieve research objectives requires expertise and experience in real-world and late phase research. Quintiles, a leader in interventional IIIb/IV studies and observational research, is the world’s largest provider of biopharmaceutical development and commercial...
Read more
Brochure
With regulators, payers, providers and patients demanding better evidence of safety and effectiveness to inform their decision-making, the diabetes landscape is becoming increasingly complex. But it’s also becoming an area of greater opportunity for drug, device and diagnostic developers who can quickly determine the right questions and deliver the right answers when it...
Read more
Brochure
The pressure to improve health outcomes is increasing from all sectors. And advances in healthcare hinge on increasingly complex questions – efficacy, effectiveness, safety and quality. With the rise of health information systems, the body of healthcare data is bigger than ever. Unlocking its potential through access, linkage and analytics is the key to recognizing...
Read more
Fact Sheet
With a large, highly concentrated population and an increasing number of trained investigators, Indonesia is positioned as an attractive setting to conduct your clinical studies and pursue market entry in Southeast Asia. With Quintiles as your local partner, you can have the right resources, expertise and relationships in place to turn your clinical and commercial goals...
Read more
Scientific Poster
> read the abstract at Therapeutic Innovation & Regulatory Science
Explore More
Press Release
RESEARCH TRIANGLE PARK, NC – February 6, 2015 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) announced today that Dr. John Leonard, MD, has been appointed to its Board of Directors, effective immediately.  Dr. Leonard will also serve as a member of the Audit and Governance Committees of the Board.   Dr. Leonard serves as chief medical...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC – February 6, 2015 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) announced today that its Board and principal shareholders have reached agreement on a governance plan to transition the Company’s Board of Directors and its committees to comply with NYSE criteria as a non-controlled company. Quintiles’...
Read More
Fact Sheet
Quintiles offers an extensive list of available ADME screening services, definitive in vitro assays, and metabolite profiling and identification services. We can also develop additional assays and customize assay design.
Read more
Fact Sheet
You know the barriers to CV innovation. Pressures on development costs. Expanding regulatory requirements. Larger, longer and more complex clinical trials. Partner with Quintiles for the global scientific, clinical and technological resources needed for successful cardiovascular drug development.
Read More
Video
Learn how remote meeting with healthcare professionals could help increase the impact of your product messages.
Video
John Doyle, DrPH, MPH and Adrian McKemey, PhD, provide insight and key takeaways from the 2014 EVF - Signals in the System: Cutting Through the Noise with Patient Insights.
White Paper
Part one of our three-part white paper discusses how biopharma can succeed in the healthcare technology transformation by adapting the way they gather, analyze and apply patient data. Authors: John Doyle, DrPH, MPH & Adrian McKemey, PhD
Explore More
Brochure
As an employee at Quintiles, you can achieve beyond what’s possible. Take a look at our brochure to learn more about how a Quintiles career will improve your probability of success.
Read More
Brochure
As an employee at Quintiles, you can achieve beyond what’s possible. Take a look at our brochure to learn more about how a Quintiles career will improve your probability of success.
Read More
Brochure
As an employee at Quintiles, you can achieve beyond what’s possible. Take a look at our brochure to learn more about how a Quintiles career will improve your probability of success.
Read More